
Unlearn.AI uses AI-generated digital twins to make clinical trials faster and more efficient by predicting patient outcomes and reducing required sample sizes. The company provides a B2B SaaS platform that applies machine learning, deep learning, and biostatistics to create prognostic digital twins and implement TwinRCTs that integrate historical data into randomized trials. Its solution is used by pharmaceutical and biotech sponsors across therapeutic areas such as neuroscience, immunology, and metabolic disease and aligns with EMA qualification and FDA guidance. Unlearn.AI’s platform supports trial simulation, responder identification, and more precise treatment-effect estimation to de-risk trial design and accelerate development timelines.

Unlearn.AI uses AI-generated digital twins to make clinical trials faster and more efficient by predicting patient outcomes and reducing required sample sizes. The company provides a B2B SaaS platform that applies machine learning, deep learning, and biostatistics to create prognostic digital twins and implement TwinRCTs that integrate historical data into randomized trials. Its solution is used by pharmaceutical and biotech sponsors across therapeutic areas such as neuroscience, immunology, and metabolic disease and aligns with EMA qualification and FDA guidance. Unlearn.AI’s platform supports trial simulation, responder identification, and more precise treatment-effect estimation to de-risk trial design and accelerate development timelines.
Core offering: AI-generated digital twins and trial-design/analysis tools to improve clinical trials
Founded: 2017
Headcount (approx.): 66
Reported total funding: 134,850,000 USD
Key customers: Pharmaceutical and biotech sponsors (multiple therapeutic areas)
| Company |
|---|
Clinical trial design and analysis for pharmaceutical and biotech development
2017
Research Services
12,000,000
Reported Series A led by 8VC with participation from DCVC, DCVC Bio, and Mubadala Capital Ventures.
50,000,000
Reported Series B with participation from Radical Ventures, 8VC, DCVC, DCVC Bio, and Mubadala.
134850000
Aggregate reported total funding amount as of this date.
“Participants include growth and specialized investors such as 8VC, Insight Partners, DCVC/DCVC Bio, Radical Ventures, Mubadala, Altimeter Capital, and Wittington Ventures”
Our Mission and Vision
Unlearn exists to transform clinical development by making every trial smarter. We harness data, AI, and digital twins to enable faster, more robust studies that bring life-saving treatments to patients faster. This mission drives everything we do as we partner with biopharmaceutical companies to redesign how clinical trials are planned, run, and analyzed.
We are defining the future of clinical development with unmatched scientific credibility, replacing uncertainty with AI-powered precision so decisions are clearer and trials are stronger. We don’t just disrupt the pharmaceutical industry, we create lasting change.
We believe AI will define the future of medicine, and we are committed to building that future responsibly, rigorously, and in close collaboration with our partners in clinical development.
About Our Team We come from a variety of backgrounds ranging from machine learning to marketing—but regardless of where we come from, Unlearners share some common traits:
Headquartered in San Francisco, Unlearn was founded in 2017 by a team of world-class machine learning scientists. We have raised venture capital from top tier investors such as Altimeter, Insight Partners, Radical Ventures, 8VC, DCVC, and DCVC Bio, and completed our $50 million Series C in January 2024.
If our purpose and culture resonate with you, we invite you to apply. The Role
We are seeking a hands-on Controller who thrives in a fast-paced, high-growth
environment at the intersection of biotech and software. This is a critical individual
contributor role where you will be responsible for all core accounting operations,
systems, and compliance while partnering with our FP&A leader on financial planning
initiatives. You will own and execute the full accounting function from month-end close
in NetSuite to payroll processing, AP/AR, legal contract reviews, and audit preparation
Reporting directly to the CFO/COO this is a high impact role where you will support
strategic planning, fund raising, financial diligence and scaling the company to the next
stage of growth.
What You'll Own
Core Accounting Operations
Technical Accounting & Compliance
Fundraising & Financial Support
What You Bring
Required Experience
Technical Skills
Personal Attributes
Ideal Candidate
You've likely held Controller, Assistant Controller, or Director of Accounting roles at
public/venture-backed startups or high-growth companies. You may have started in Big
4 audit (life sciences or tech practice) before transitioning to industry. You've been
through at least one major financing event (Series B+ or IPO readiness) and know how
to support rigorous due diligence processes.
You're Equally Comfortable
Benefits & Perks
The following benefits and perks are for full time roles only.
Unlearn is an equal opportunity employer.
At Unlearn, we are committed to building a diverse and inclusive workplace, because inclusion and diversity are essential to achieving our mission. If you’re excited about this role, and your past experience doesn’t align perfectly with every qualification in the job description, we encourage you to apply nevertheless.